American Journal of Cardiology
Volume 103, Issue 9 , Pages 1189-1195 , 1 May 2009

Incidence, Predictors, and Outcome of New, Subsequent Lesions Treated With Percutaneous Coronary Intervention in Patients Presenting With Myocardial Infarction

Received 12 December 2008 ,Revised 9 January 2009 ,Accepted 9 January 2009.

References 

  1. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343:915–922
  2. Muller DW, Topol EJ, Ellis SG, Sigmon KN, Lee K, Califf RM. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction (Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group). Am Heart J. 1991;121:1042–1049
  3. Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol. 2006;98:352–356
  4. Rioufol G, Finet G, Ginon I, André-Fouët X, Rossi R, Vialle E, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation. 2002;106:804–808
  5. Rioufol G, Zeller M, Dentan G, Laurent Y, L'Huillier I, Ravisy J, et al. Predictors and prognosis for complex coronary lesions in patients with acute myocardial infarction: data from RICO survey. Am Heart J. 2007;154:330–335
  6. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Kataiwa H, et al Distribution and frequency of thin-capped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography. Am J Cardiol. 2008;102:975–979
  7. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44(suppl):E1–E211
  8. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;51:210–247
  9. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, et al American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention (ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)). J Am Coll Cardiol. 2006;47:216–235
  10. Ambrose JA, Winters SL, Arora RR, Haft JI, Goldstein J, Rentrop KP, et al. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol. 1985;6:1233–1238
  11. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, et al. Patterns of calcification in coronary artery disease (A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions). Circulation. 1995;91:1959–1965
  12. Patti G, Colonna G, Pasceri V, Pepe LL, Montinaro A, Di Sciascio G. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 2005;111:2099–2106
  13. Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. J Am Coll Cardiol. 2008;52:1128–1133
  14. Wenaweser P, Rey C, Eberli FR, Togni M, Tüller D, Locher S, et al. Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J. 2005;26:1180–1187
  15. Glaser R, Selzer F, Faxon DP, Laskey WK, Cohen HA, Slater J, et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation. 2005;111:143–149
  16. Chen YL, Chen MC, Wu CJ, Yip HK, Fang CY, Hsieh YK, et al. Impact of 6-month angiographic restenosis inside bare-metal stents on long-term clinical outcome in patients with coronary artery disease. Int Heart J. 2007;48:443–454
  17. Cosgrave J, Melzi G, Biondi-Zoccai GG, Airoldi F, Chieffo A, Sangiorgi GM, et al. Drug-eluting stent restenosis the pattern predicts the outcome. J Am Coll Cardiol. 2006;47:2399–2404
  18. Migliorini A, Shehu M, Carrabba N, Giurlani L, Valenti R, Buonamici P, et al. Predictors of outcome after sirolimus-eluting stent implantation for complex in-stent restenosis. Am J Cardiol. 2005;96:1110–1112
  19. Arjomand H, Willerson JT, Holmes DR, Bamlet WR, Surabhi SK, Roukoz B, et al. Outcome of patients with prior percutaneous revascularization undergoing repeat coronary intervention (from the PRESTO Trial). Am J Cardiol. 2005;96:741–746

PII: S0002-9149(09)00124-6

doi: 10.1016/j.amjcard.2009.01.029

American Journal of Cardiology
Volume 103, Issue 9 , Pages 1189-1195 , 1 May 2009